Biogen Announces News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biogen announces. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biogen Announces Today - Breaking & Trending Today

Biogen Announces $7.3 Billion Acquisition Of Reata Pharmaceuticals

Reata stock surged more than 50% on the news. The post Biogen Announces $7.3 Billion Acquisition Of Reata Pharmaceuticals appeared first on Investor's… ....

Reata Pharmaceuticals , Biogen Announces , Acquisition Of Reata Pharmaceuticals , Reaking News ,

Investegate |Biogen Inc. Announcements | Biogen Inc.: Biogen Announces the Pricing Terms of its Cash Tender Offer

Biogen Announces the Pricing Terms of its Cash Tender Offer
CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the pricing terms of its previously announced offer to purchase for cash (the “Cash Offer”) its outstanding 5.200% Senior Notes due 2045 (the “Notes”), totaling $1.75 billion in aggregate principal amount, on the terms and subject to the conditions set forth in the Offer to Purchase dated February 4, 2021 (the “Offer to Purchase”) and the accompanying certification of eligibility to participate in the Cash Offer, the instructions for such certification and the notice of guaranteed delivery (collectively, the “Cash Offer Documents”). ....

New York , United States , United Kingdom , David Caouette , Mike Hencke , Walter Gilbert , Charles Weissmann , Heinz Schaller , Kenneth Murray , Exchange Commission , Exchange Offer The Completion Condition , Exchange Offer Completion Condition , Biogen Inc , Global Bondholder Services Corporation , Biogen Announces , Pricing Terms , Cash Tender , Senior Notes , Cash Offer , Tender Consideration , Expiration Date , New York City , Ineligible Holders , Maximum Cash Offer , Accrued Coupon Payment , Securities Act ,

Investegate |Biogen Inc. Announcements | Biogen Inc.: Biogen Announces the Pricing Terms of Its Private Exchange Offer

Biogen Announces the Pricing Terms of Its Private Exchange Offer
CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the pricing terms of its previously announced private offer to exchange (the “Exchange Offer”) any and all of its outstanding 5.200% Senior Notes due 2045 (the “Old Notes”), totaling $1.75 billion in aggregate principal amount, for a new series of 3.250% senior notes due 2051 to be issued by Biogen (the “New Notes”) and cash on the terms and subject to the conditions set forth in the Offering Memorandum dated February 4, 2021 (the “Offering Memorandum”) and the accompanying eligibility letter (the “Eligibility Letter”), Canadian beneficial holder form and notice of guaranteed delivery (collectively, the “Exchange Offer Documents”). ....

New York , United States , United Kingdom , David Caouette , Mike Hencke , Walter Gilbert , Charles Weissmann , Heinz Schaller , Kenneth Murray , Exchange Commission , Exchange Consideration , Exchange Consideration For The Old , Biogen Inc , Global Bondholder Services Corporation , Exchange Offer , Biogen Announces , Pricing Terms , Its Private Exchange Offer , Senior Notes , Offering Memorandum , Old Notes , New Notes , Total Exchange Consideration , Expiration Date , New York City , Cash Payment Percent ,